Discover how the S&P 500 Index performed in 2024 and what that could mean for the first quarter of 2025 according to Barclays ...

Investment firm Barclays laid out its thoughts for the technology space in 2025 in a research note on Thursday, covering ...

BTS member J-Hope reveals his first-ever solo tour, hitting venues in 2025 in North America and Asia for Hope on the Stage ...

Barclays analyst Peter Lawson maintained a Hold rating on Blueprint Medicines (BPMC – Research Report) today and set a price target of $105.00.

In a report released today, Seth Sigman from Barclays maintained a Hold rating on Five Below (FIVE – Research Report), with a price target of ...

Russo also swept our club awards last month, clinching the Goal of the Month and women's Player of the Month accolades. She ...

MILLENNIUM Management spinoff Modular Asset Management plans to expand to Hong Kong, the latest hedge fund arrival as the ...

On Wednesday, Barclays PLC (BCS) stock saw a decline, ending the day at $13.19 which represents a decrease of $-0.06 or -0.45% from the prior close of $13.25. The stock opened at $13.01 and touched a ...

Is the Premier League about to witness the latest triumphant return of Jose Mourinho (actual triumph to be confirmed)? He's ...

Barclays raised its price target on Ulta Beauty Inc (NASDAQ:ULTA) to $445 from $410 on stronger-than-expected preliminary ...

We recently published a list of 15 AI Stocks That Skyrocketed in Q4. In this article, we are going to take a look at where ...

Barclays PLC lifted its holdings in shares of Regulus Therapeutics Inc. (NASDAQ:RGLS – Free Report) by 285.2% during the 3rd quarter, Holdings Channel reports. The firm owned 84,477 shares of the ...